130 related articles for article (PubMed ID: 22277719)
21. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in the horse.
Rezende ML; Grimsrud KN; Stanley SD; Steffey EP; Mama KR
J Vet Pharmacol Ther; 2015 Feb; 38(1):15-23. PubMed ID: 25066475
[TBL] [Abstract][Full Text] [Related]
22. Bioavailability of dexmedetomidine after intranasal administration.
Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT
Eur J Clin Pharmacol; 2011 Aug; 67(8):825-31. PubMed ID: 21318594
[TBL] [Abstract][Full Text] [Related]
23. Effects of different doses of L-659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine.
Restitutti F; Honkavaara JM; Raekallio MR; Kuusela EK; Vainio OM
Vet Anaesth Analg; 2011 Sep; 38(5):415-22. PubMed ID: 21831046
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of dexmedetomidine, with and without MK-467, following intramuscular administration in cats anesthetized with isoflurane.
Siao KT; Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Sep; 44(5):1101-1115. PubMed ID: 29056418
[TBL] [Abstract][Full Text] [Related]
25. Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study.
Santangelo B; Harel M; Fourel I; Micieli F; Cataldi M; Segard-Weisse E; Portier K
Vet J; 2019 Sep; 251():105346. PubMed ID: 31492384
[TBL] [Abstract][Full Text] [Related]
26. The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats.
Honkavaara J; Pypendop B; Ilkiw J
Vet Anaesth Analg; 2017 Jul; 44(4):811-822. PubMed ID: 28734853
[TBL] [Abstract][Full Text] [Related]
27. Comparison of three anaesthetic protocols in Bennett's wallabies (Macropus rufogriseus).
Bouts T; Harrison N; Berry K; Taylor P; Routh A; Gasthuys F
Vet Anaesth Analg; 2010 May; 37(3):207-14. PubMed ID: 20230552
[TBL] [Abstract][Full Text] [Related]
28. Effects of the α
Bennett RC; Salla KM; Raekallio MR; Scheinin M; Vainio OM
Am J Vet Res; 2017 Aug; 78(8):956-964. PubMed ID: 28738010
[TBL] [Abstract][Full Text] [Related]
29. The impact of MK-467 on plasma drug concentrations, sedation and cardiopulmonary changes in sheep treated with intramuscular medetomidine and atipamezole for reversal.
Adam M; Raekallio MR; Keskitalo T; Honkavaara JM; Scheinin M; Kajula M; Mölsä S; Vainio OM
J Vet Pharmacol Ther; 2018 Jun; 41(3):447-456. PubMed ID: 29352473
[TBL] [Abstract][Full Text] [Related]
30. The effects of L-659,066, a peripheral alpha2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs.
Honkavaara JM; Raekallio MR; Kuusela EK; Hyvärinen EA; Vainio OM
Vet Anaesth Analg; 2008 Sep; 35(5):409-13. PubMed ID: 18466161
[TBL] [Abstract][Full Text] [Related]
31. Effects of dexmedetomidine on glucose homeostasis in healthy cats.
Bouillon J; Duke T; Focken AP; Snead EC; Cosford KL
J Feline Med Surg; 2020 Apr; 22(4):344-349. PubMed ID: 31090471
[TBL] [Abstract][Full Text] [Related]
32. Population Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Children Undergoing Ambulatory Surgery.
Pérez-Guillé MG; Toledo-López A; Rivera-Espinosa L; Alemon-Medina R; Murata C; Lares-Asseff I; Chávez-Pacheco JL; Gómez-Garduño J; Zamora Gutiérrez AL; Orozco-Galicia C; Ramírez-Morales K; Lugo-Goytia G
Anesth Analg; 2018 Sep; 127(3):716-723. PubMed ID: 29782406
[TBL] [Abstract][Full Text] [Related]
33. The impact of medetomidine on the protein-binding characteristics of MK-467 in canine plasma.
Bennett RC; Hokkanen J; Raekallio MR; Vainio OM
J Vet Pharmacol Ther; 2016 Aug; 39(4):405-7. PubMed ID: 26763140
[TBL] [Abstract][Full Text] [Related]
34. Effects of acepromazine or dexmedetomidine on fentanyl disposition in dogs during recovery from isoflurane anesthesia.
Keating S; Kerr C; McDonell W; Valverde A; Johnson R; Knych H; Edginton A
Vet Anaesth Analg; 2016 Jan; 43(1):35-43. PubMed ID: 25943714
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial.
Song JC; Gao H; Qiu HB; Chen QB; Cai MH; Zhang MZ; Lu ZJ
PLoS One; 2018; 13(11):e0207427. PubMed ID: 30427948
[TBL] [Abstract][Full Text] [Related]
37. Peripheral α
Kallio-Kujala IJ; Raekallio MR; Honkavaara J; Bennett RC; Turunen H; Scheinin M; Hautajärvi H; Vainio O
Vet Anaesth Analg; 2018 Jul; 45(4):405-413. PubMed ID: 29891212
[TBL] [Abstract][Full Text] [Related]
38. Effect of dexmedetomidine on the minimum infusion rate of propofol preventing movement in dogs.
Smith CK; Seddighi R; Cox SK; Sun X; Knych HK; Doherty TJ
Vet Anaesth Analg; 2017 Nov; 44(6):1287-1295. PubMed ID: 29074303
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of dexmedetomidine in isoflurane-anesthetized cats.
Pypendop BH; Barter LS; Stanley SD; Ilkiw JE
Vet Anaesth Analg; 2011 Nov; 38(6):555-67. PubMed ID: 21988810
[TBL] [Abstract][Full Text] [Related]
40. The pharmacokinetics of dexmedetomidine administered as a constant rate infusion in horses.
Ranheim B; Risberg ÅI; Spadavecchia C; Landsem R; Haga HA
J Vet Pharmacol Ther; 2015 Feb; 38(1):93-6. PubMed ID: 25229603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
